Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
University of Ulm University Hospital Ulm |
---|---|
Information provided by: | University of Ulm |
ClinicalTrials.gov Identifier: | NCT00710411 |
The purpose of this study is to determine the inflammatory response after multiple trauma in humans.
Condition |
---|
Multiple Trauma |
Study Type: | Observational |
Study Design: | Case Control, Prospective |
Official Title: | Inflammatory Response in Polytraumatized Patients |
Whole blood, serum, white cells, and tissues will be retained.
Estimated Enrollment: | 90 |
Study Start Date: | April 2009 |
Estimated Study Completion Date: | December 2011 |
Groups/Cohorts |
---|
A, 2
Polytraumatized patients with ISS > 18 and healthy controls
|
Polytraumatized patients are via a systemic inflammatory response syndrome at high risk for an uneventful outcome in the posttraumatic phase. One of the main functions of the inflammatory response is the recognition and elimination of damaged tissues and microorganisms. In polytraumatized patients, a huge amount of damaged cells occurs which has to be eliminated by programmed cell death (apoptosis)without damaging surrounding tissues. It remains unclear whether, when and how an interplay of complement system, NF-kB, danger and pattern recognition receptors, apoptosis, mesenchymal stem cells and their regulation may be beneficial and harmful. Differing activation of the complement system, pro-inflammatory biomarkers and predisposing polymorphisms of response and receptor genes are expected to lead to varying outcome. Therefore, this prospective observational study will enroll n=60 polytraumatized patients with an ISS>18 to monitor longitudinally their inflammatory response after trauma and to find out whether there is a discriminating pattern of the cross talk between complement system, biomarkers and apoptosis in patients with beneficial or harmful outcome.
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Polytraumatized patients with an ISS > 18 Controls: healthy volunteers
Inclusion Criteria:
multiple trauma injury, injury severity score (ISS) > 18 with
Exclusion Criteria:
Contact: Manfred M Weiss, MD, MBA | +49 - (0)731-500-60226 | manfred.weiss@uniklinik-ulm.de |
Contact: Markus M Huber-Lang, MD | +49 - (0)731-500-54569 | markus.huber-lang@uniklinik-ulm.de |
Germany | |
Clinic of Anesthesiology and Clinic of Traumatology, Hand-, Plastic-, and Reconstructive Surgery | Recruiting |
Ulm, Germany, 89070 | |
Contact: Manfred M Weiss, MD, MBA +49-(0)731-500-60226 manfred.weiss@uniklinik-ulm.de | |
Contact: Markus M Huber-Lang, MD +49-(0)731-500-54569 markus.huber-lang@uniklinik-ulm.de | |
Principal Investigator: Markus M Huber-Lang, MD | |
Sub-Investigator: Marion M Schneider, PhD | |
Sub-Investigator: Florian F Gebhard, MD | |
Sub-Investigator: Michael M Georgieff, MD | |
Sub-Investigator: Heidemarie H Suger-Wiedeck, MD | |
Sub-Investigator: Karl K Traeger, MD | |
Sub-Investigator: Uwe U Senftleben, MD | |
Sub-Investigator: Florian F Wagner, MD | |
Sub-Investigator: Miriam M Kalbitz, MD | |
Sub-Investigator: Mario M Perl, MD | |
Sub-Investigator: Doris D Henne-Bruns, MD | |
Principal Investigator: Ludger L Sunder-Plassmann, MD | |
Sub-Investigator: Dieter D Woischnek, MD | |
Sub-Investigator: Heiko H Reichel, MD | |
Sub-Investigator: Rolf R Brenner, MD | |
Sub-Investigator: Joerg J Fiedler, MD | |
Sub-Investigator: Barbara B Acker |
Principal Investigator: | Manfred M Weiss, MD, MBA | Clinic of Anesthesiology, University Hospital Medical School, Steinhoevelstrasse 9, 89070 Ulm, Germany |
Responsible Party: | Depts. Anesthesiology and. Traumatology, Hand-, Plastic-, Reconstr. Surgery Ulm ( Weiss Manfred/Associate Professor, MD, MBA; Huber-Lang Markus, Associate Professor, MD ) |
Study ID Numbers: | DFG KFO-200 |
Study First Received: | July 2, 2008 |
Last Updated: | April 1, 2009 |
ClinicalTrials.gov Identifier: | NCT00710411 History of Changes |
Health Authority: | Germany: Federal Ministry of Education and Research |
humans patients polytrauma complement inflammation inflammatory response biomarkers cytokines cell surface markers apoptosis NF-kappaB functional polymorphisms mesenchymal stem cell severity of injury ISS |
infections systemic inflammatory response syndrome SIRS sepsis severe sepsis shock organ dysfunctions SOFA severity of disease APACHEII SAPSII SPAPS3 length of stay wound healing outcome |
Systemic Inflammatory Response Syndrome Carisoprodol Multiple Trauma Sepsis |
Shock Wounds and Injuries Disorders of Environmental Origin Inflammation |
Multiple Trauma Wounds and Injuries Disorders of Environmental Origin |